UNDERUTILIZATION OF STATIN THERAPY AFTER A CARDIOVASCULAR EVENT OR DIABETES DIAGNOSIS IN THREE REAL-WORLD DATA SYSTEMS
| Autor: | Paul Muntner, Jill Hardin, Yi Peng, Brian D. Bradbury, Anne Beaubrun, Charles Herzog, Robert Rosenson, Keri L. Monda, Katherine E Mues, Suying Li, Deborah Kim |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Cardiovascular event
medicine.medical_specialty endocrine system diseases Diabetes diagnosis business.industry nutritional and metabolic diseases Type 2 Diabetes Mellitus Disease Internal medicine medicine Cardiology cardiovascular diseases Claims database Statin therapy Cardiology and Cardiovascular Medicine Intensive care medicine business Real world data |
| Zdroj: | Journal of the American College of Cardiology. 67:1977 |
| ISSN: | 0735-1097 |
| DOI: | 10.1016/s0735-1097(16)31978-7 |
| Popis: | US guidelines recommend use of statins for patients with cardiovascular disease (CVD) or type 2 diabetes mellitus (T2DM). We estimated the use of statins after an atherosclerotic CVD event or a diagnosis of T2DM in two commercial claims databases, MarketScan and Optum, and a 5% sample of Medicare |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|